23145119|t|Caprylic triglyceride as a novel therapeutic approach to effectively improve the performance and attenuate the symptoms due to the motor neuron loss in ALS disease.
23145119|a|Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder of motor neurons causing progressive muscle weakness, paralysis, and finally death. ALS patients suffer from asthenia and their progressive weakness negatively impacts quality of life, limiting their daily activities. They have impaired energy balance linked to lower activity of mitochondrial electron transport chain enzymes in ALS spinal cord, suggesting that improving mitochondrial function may present a therapeutic approach for ALS. When fed a ketogenic diet, the G93A ALS mouse shows a significant increase in serum ketones as well as a significantly slower progression of weakness and lower mortality rate. In this study, we treated SOD1-G93A mice with caprylic triglyceride, a medium chain triglyceride that is metabolized into ketone bodies and can serve as an alternate energy substrate for neuronal metabolism. Treatment with caprylic triglyceride attenuated progression of weakness and protected spinal cord motor neuron loss in SOD1-G93A transgenic animals, significantly improving their performance even though there was no significant benefit regarding the survival of the ALS transgenic animals. We found that caprylic triglyceride significantly promoted the mitochondrial oxygen consumption rate in vivo. Our results demonstrated that caprylic triglyceride alleviates ALS-type motor impairment through restoration of energy metabolism in SOD1-G93A ALS mice, especially during the overt stage of the disease. These data indicate the feasibility of using caprylic acid as an easily administered treatment with a high impact on the quality of life of ALS patients.
23145119	0	21	Caprylic triglyceride	Chemical	MESH:C003637
23145119	131	148	motor neuron loss	Disease	MESH:D016472
23145119	152	163	ALS disease	Disease	MESH:D000690
23145119	165	194	Amyotrophic lateral sclerosis	Disease	MESH:D000690
23145119	196	199	ALS	Disease	MESH:D000690
23145119	206	232	neurodegenerative disorder	Disease	MESH:D019636
23145119	270	285	muscle weakness	Disease	MESH:D018908
23145119	287	296	paralysis	Disease	MESH:D010243
23145119	317	320	ALS	Disease	MESH:D000690
23145119	321	329	patients	Species	9606
23145119	342	350	asthenia	Disease	MESH:D001247
23145119	373	381	weakness	Disease	MESH:D018908
23145119	563	566	ALS	Disease	MESH:D000690
23145119	668	671	ALS	Disease	MESH:D000690
23145119	704	708	G93A	DNAMutation	tmVar:c|SUB|G|93|A;HGVS:c.93G>A;VariantGroup:0;OriginalGene:20655;CorrespondingGene:6647;CorrespondingSpecies:10090
23145119	709	712	ALS	Disease	MESH:D000690
23145119	713	718	mouse	Species	10090
23145119	757	764	ketones	Chemical	MESH:D007659
23145119	814	822	weakness	Disease	MESH:D018908
23145119	875	879	SOD1	Gene	20655
23145119	880	884	G93A	DNAMutation	tmVar:c|SUB|G|93|A;HGVS:c.93G>A;VariantGroup:0;OriginalGene:20655;CorrespondingGene:6647;CorrespondingSpecies:10090
23145119	885	889	mice	Species	10090
23145119	895	916	caprylic triglyceride	Chemical	MESH:C003637
23145119	933	945	triglyceride	Chemical	MESH:D014280
23145119	971	984	ketone bodies	Chemical	MESH:D007657
23145119	1072	1093	caprylic triglyceride	Chemical	MESH:C003637
23145119	1120	1128	weakness	Disease	MESH:D018908
23145119	1155	1172	motor neuron loss	Disease	MESH:D016472
23145119	1176	1180	SOD1	Gene	20655
23145119	1181	1185	G93A	DNAMutation	tmVar:c|SUB|G|93|A;HGVS:c.93G>A;VariantGroup:0;OriginalGene:20655;CorrespondingGene:6647;CorrespondingSpecies:10090
23145119	1323	1326	ALS	Disease	MESH:D000690
23145119	1361	1382	caprylic triglyceride	Chemical	MESH:C003637
23145119	1424	1430	oxygen	Chemical	MESH:D010100
23145119	1487	1508	caprylic triglyceride	Chemical	MESH:C003637
23145119	1520	1523	ALS	Disease	MESH:D000690
23145119	1529	1545	motor impairment	Disease	MESH:D000068079
23145119	1590	1594	SOD1	Gene	20655
23145119	1595	1599	G93A	DNAMutation	tmVar:c|SUB|G|93|A;HGVS:c.93G>A;VariantGroup:0;OriginalGene:20655;CorrespondingGene:6647;CorrespondingSpecies:10090
23145119	1600	1603	ALS	Disease	MESH:D000690
23145119	1604	1608	mice	Species	10090
23145119	1705	1718	caprylic acid	Chemical	MESH:C031492
23145119	1800	1803	ALS	Disease	MESH:D000690
23145119	1804	1812	patients	Species	9606
23145119	Positive_Correlation	MESH:D007659	MESH:D000690
23145119	Association	MESH:D007659	HGVS:c.93G>A;CorrespondingGene:6647
23145119	Negative_Correlation	MESH:C003637	MESH:D016472
23145119	Positive_Correlation	MESH:C003637	MESH:D010100
23145119	Negative_Correlation	MESH:C003637	MESH:D000690
23145119	Association	MESH:C031492	MESH:D000690
23145119	Negative_Correlation	MESH:C003637	MESH:D018908
23145119	Association	MESH:C003637	MESH:D007657
23145119	Negative_Correlation	MESH:C003637	MESH:D000068079

